Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia

ClinicalTrials.gov ID: NCT04103450

Public ClinicalTrials.gov record NCT04103450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the long-term safety of vibegron when dosed up to 52 weeks in men with overactive bladder (OAB) symptoms on pharmacological therapy for Benign Prostatic Hyperplasia (BPH) who previously completed treatment in Study URO-901-3005 (NCT03902080).

Study identification

NCT ID
NCT04103450
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Urovant Sciences GmbH
Industry
Enrollment
276 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2019 (Actual)
Primary completion
Jul 29, 2022 (Actual)
Completion
Jul 29, 2022 (Actual)
Last update posted
Aug 21, 2024

2019 – 2022

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Private Practice Huntsville Alabama 35801 —
Clinical Trials Research Lincoln California 95648 —
American Institute of Research Los Angeles California 90017 —
Tri Valley Urology Medical Group Murrieta California 92562 —
Northern California Research Corp Sacramento California 95821 —
San Diego Clinical Trials San Diego California 91942 —
Skyline Urology Torrance California 90505 —
Imagine Research of Palm Beach County - Urology Boynton Beach Florida 33435 —
Tampa Bay Medical Research Clearwater Florida 33761 —
Quantum Clinical Trials Miami Florida 33140 —
Urology Center Of Florida Pompano Beach Florida 33060 —
Precision Clinical Research Sunrise Florida 33351 —
Clinical Research of Central Florida Winter Haven Florida 33880 —
DelRicht Research New Orleans Louisiana 70115 —
Regional Urology, LLC Shreveport Louisiana 71106 —
Boston Clinical Trials Inc - Urology Boston Massachusetts 02131 —
Bay State Clinical Trials, Inc. Watertown Massachusetts 02472 —
Beaumont Hospital Royal Oak - Urology Research Royal Oak Michigan 48703 —
CentraCare Clinic - Adult & Pediatric Urology Sartell Minnesota 56377 —
Poplar Bluff Urology Poplar Bluff Missouri 63901 —
Adult & Pediatric Urology P.C. - Urology Omaha Nebraska 68114 —
Excel Clinical Research - Internal Medicine Las Vegas Nevada 89109 —
Private Practice Las Vegas Nevada 89144 —
Premier Urology Group, LLC Edison New Jersey 08837 —
New Jersey Urology NJU Englewood New Jersey 07631 —
AccuMed Research Associates Garden City New York 11530 —
Urological Surgeons of Long Island Garden City New York 11530 —
Clinical Research Solutions Middleburg Heights Ohio 44130 —
Advances In Health, Inc. Houston Texas 77030 —
Wasatch Clinical Research LLC Salt Lake City Utah 84107 —
Seattle Urology Research Center Burien Washington 98166 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04103450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2024 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04103450 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →